Test tubes labelled "Monkeypox virus positive and negative" are seen in this illustration taken May 23, 2022. [Photo/Agencies] ================================================================= A domestic monkeypox vaccine candidate developed by Chinese drugmaker Sinopharm received clearance from the top drug regulator for clinical trials on Monday, representing the nation's first experimental dose to win the trial approval, said the company. The vaccine candidate is created by Shanghai Institute of Biological Products administered by Sinopharm and is expected to play an important role in preventing and controlling monkeypox infections, said the company in a statement released on Monday afternoon. In China, a vaccine candidate typically goes...